To determine whether FOXM1 and TPX2 were associated with the clinical outcomes of patients with HCC, we performed a Kaplan-Meier survival analysis of HCC patients grouped by immunochemistry-assessed FOXM1 and TPX2 protein levels. The gene discussed is FOXM1; the disease is hepatocellular carcinoma.